BACKGROUND. Patients with congestive heart failure have a high mortality rate and are also hospitalized frequently. We studied the effect of an angiotensin-converting-enzyme inhibitor, enalapril, on mortality and hospitalization in patients with chronic heart failure and ejection fractions less than or equal to 0.35. METHODS. Patients receiving conventional treatment for heart failure were randomly assigned to receive either placebo (n = 1284) or enalapril (n = 1285) at doses of 2.5 to 20 mg per day in a double-bind trial. Approximately 90 percent of the patients were in New York Heart Association functional classes II and III. The follow-up averaged 41.4 months. RESULTS. There were 510 deaths in the placebo group (39.7 percent), as compared with 452 in the enalapril group (35.2 percent) (reduction in risk, 16 percent; 95 percent confidence interval, 5 to 26 percent; P = 0.0036). Although reductions in mortality were observed in several categories of cardiac deaths, the largest reduction occurred among the deaths attributed to progressive heart failure (251 in the placebo group vs. 209 in the enalapril group; reduction in risk, 22 percent; 95 percent confidence interval, 6 to 35 percent). There was little apparent effect of treatment on deaths classified as due to arrhythmia without pump failure. Fewer patients died or were hospitalized for worsening heart failure (736 in the placebo group and 613 in the enalapril group; risk reduction, 26 percent; 95 percent confidence interval, 18 to 34 percent; P less than 0.0001). CONCLUSIONS. The addition of enalapril to conventional therapy significantly reduced mortality and hospitalizations for heart failure in patients with chronic congestive heart failure and reduced ejection fractions.
This article has been cited by other articles:
Teo, K. K.
(2009). Clinical evidence from ONTARGET: proven cardio- and vascular protection. Eur Heart J Suppl
11: F9-F15
[Abstract][Full Text]
Bohm, M., Mahfoud, F., Werner, C., Teo, K., Baumhakel, M.
(2009). Cardiovascular protection: a breakthrough for high-risk patients. Eur Heart J Suppl
11: F19-F26
[Abstract][Full Text]
Slaughter, M. S., Rogers, J. G., Milano, C. A., Russell, S. D., Conte, J. V., Feldman, D., Sun, B., Tatooles, A. J., Delgado, R. M. III, Long, J. W., Wozniak, T. C., Ghumman, W., Farrar, D. J., Frazier, O. H., the HeartMate II Investigators,
(2009). Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist Device. NEJM
0: NEJMoa0909938v1-1
[Abstract][Full Text]
Zhang, Y., Popovic, Z. B., Bibevski, S., Fakhry, I., Sica, D. A., Van Wagoner, D. R., Mazgalev, T. N.
(2009). Chronic Vagus Nerve Stimulation Improves Autonomic Control and Attenuates Systemic Inflammation and Heart Failure Progression in a Canine High-Rate Pacing Model. Circ Heart Fail
2: 692-699
[Abstract][Full Text]
Klapholz, M., Abraham, W. T., Ghali, J. K., Ponikowski, P., Anker, S. D., Knusel, B., Sun, Y., Wasserman, S. M., van Veldhuisen, D. J.
(2009). The safety and tolerability of darbepoetin alfa in patients with anaemia and symptomatic heart failure. Eur J Heart Fail
11: 1071-1077
[Abstract][Full Text]
Foley, P. W.X., Leyva, F., Frenneaux, M. P.
(2009). What is treatment success in cardiac resynchronization therapy?. Europace
11: v58-v65
[Abstract][Full Text]
Ahmet, I., Morrell, C., Lakatta, E. G., Talan, M. I.
(2009). Therapeutic Efficacy of a Combination of a {beta}1-Adrenoreceptor (AR) Blocker and {beta}2-AR Agonist in a Rat Model of Postmyocardial Infarction Dilated Heart Failure Exceeds That of a {beta}1-AR Blocker plus Angiotensin-Converting Enzyme Inhibitor. J. Pharmacol. Exp. Ther.
331: 178-185
[Abstract][Full Text]
Caldwell, J. C., Contractor, H., Petkar, S., Ali, R., Clarke, B., Garratt, C. J., Neyses, L., Mamas, M. A.
(2009). Atrial fibrillation is under-recognized in chronic heart failure: insights from a heart failure cohort treated with cardiac resynchronization therapy. Europace
11: 1295-1300
[Abstract][Full Text]
Akbari, A., Knoll, G., Ferguson, D., McCormick, B., Davis, A., Biyani, M.
(2009). ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN PERITONEAL DIALYSIS: SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS. pdi
29: 554-561
[Abstract][Full Text]
Simoons, M. L.
(2009). Angiotensin-converting enzyme inhibition by perindopril in cardiovascular disease. Eur Heart J Suppl
11: E4-E8
[Abstract][Full Text]
Ferrari, R.
(2009). Cardiovascular protection by angiotensin-converting enzyme inhibition. Eur Heart J Suppl
11: E1-E3
[Full Text]
Baliga, V., Sapsford, R.
(2009). Review article: Diabetes mellitus and heart failure -- an overview of epidemiology and management. Diabetes and Vascular Disease Research
6: 164-171
[Abstract]
Nicolosi, G. L., Golcea, S., Ceconi, C., Parrinello, G., Decarli, A., Chiariello, M., Remme, W. J., Tavazzi, L., Ferrari, R., on behalf of the PREAMI Investigators,
(2009). Effects of perindopril on cardiac remodelling and prognostic value of pre-discharge quantitative echocardiographic parameters in elderly patients after acute myocardial infarction: the PREAMI echo sub-study. Eur Heart J
30: 1656-1665
[Abstract][Full Text]
Mamas, M. A., Caldwell, J. C., Chacko, S., Garratt, C. J., Fath-Ordoubadi, F., Neyses, L.
(2009). A meta-analysis of the prognostic significance of atrial fibrillation in chronic heart failure. Eur J Heart Fail
11: 676-683
[Abstract][Full Text]
Lee, D. S., Gona, P., Vasan, R. S., Larson, M. G., Benjamin, E. J., Wang, T. J., Tu, J. V., Levy, D.
(2009). Relation of Disease Pathogenesis and Risk Factors to Heart Failure With Preserved or Reduced Ejection Fraction: Insights From the Framingham Heart Study of the National Heart, Lung, and Blood Institute. Circulation
119: 3070-3077
[Abstract][Full Text]
Winter, M M, Bouma, B J, Groenink, M, Konings, T C, Tijssen, J G P, van Veldhuisen, D J, Mulder, B J M
(2009). Latest insights in therapeutic options for systemic right ventricular failure: a comparison with left ventricular failure. Heart
95: 960-963
[Abstract][Full Text]
Brugts, J. J., Ninomiya, T., Boersma, E., Remme, W. J., Bertrand, M., Ferrari, R., Fox, K., MacMahon, S., Chalmers, J., Simoons, M. L.
(2009). The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials. Eur Heart J
30: 1385-1394
[Abstract][Full Text]
Agricola, E., Ielasi, A., Oppizzi, M., Faggiano, P., Ferri, L., Calabrese, A., Vizzardi, E., Alfieri, O., Margonato, A.
(2009). Long-term prognosis of medically treated patients with functional mitral regurgitation and left ventricular dysfunction. Eur J Heart Fail
11: 581-587
[Abstract][Full Text]
Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., Michl, K., Oates, J. A., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W.
(2009). 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol
53: e1-e90
[Full Text]
Jessup, M., Abraham, W. T., Casey, D. E., Feldman, A. M., Francis, G. S., Ganiats, T. G., Konstam, M. A., Mancini, D. M., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W.
(2009). 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol
53: 1343-1382
[Full Text]
2009 WRITING GROUP TO REVIEW NEW EVIDENCE AND UPDA, , Jessup, M., Abraham, W. T., Casey, D. E., Feldman, A. M., Francis, G. S., Ganiats, T. G., Konstam, M. A., Mancini, D. M., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W.
(2009). 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation. Circulation
119: 1977-2016
[Full Text]
2005 WRITING COMMITTEE MEMBERS, , Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., Michl, K., Oates, J. A., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W.
(2009). 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation. Circulation
119: e391-e479
[Full Text]
Calvert, M. J, Shankar, A., McManus, R. J, Ryan, R., Freemantle, N.
(2009). Evaluation of the management of heart failure in primary care. Fam Pract
26: 145-153
[Abstract][Full Text]
Hobbs, F.D.R.
(2009). Clinical burden and health service challenges of chronic heart failure. Eur J Heart Fail Suppl
8: i1-i4
[Full Text]
Shen, J.-B., Shutt, R., Agosto, M., Pappano, A., Liang, B. T.
(2009). Reversal of cardiac myocyte dysfunction as a unique mechanism of rescue by P2X4 receptors in cardiomyopathy. Am. J. Physiol. Heart Circ. Physiol.
296: H1089-H1095
[Abstract][Full Text]
Massie, B. M., Collins, J. F., Ammon, S. E., Armstrong, P. W., Cleland, J. G.F., Ezekowitz, M., Jafri, S. M., Krol, W. F., O'Connor, C. M., Schulman, K. A., Teo, K., Warren, S. R., for the WATCH Trial Investigators,
(2009). Randomized Trial of Warfarin, Aspirin, and Clopidogrel in Patients With Chronic Heart Failure: The Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) Trial. Circulation
119: 1616-1624
[Abstract][Full Text]
Amato, J. L. Jr., Amato, J. L. Sr., Ghali, J. K., Tomoda, H., Schillaci, G., Pucci, G., Pirro, M., Massie, B. M., Carson, P. E., the I-PRESERVE Investigators,
(2009). Irbesartan for Heart Failure with Preserved Ejection Fraction. NEJM
360: 1256-1259
[Full Text]
Cleland, J. G.F., Cullington, D.
(2009). Digoxin: Quo Vadis?. Circ Heart Fail
2: 81-85
[Full Text]
Levy, W. C., Mozaffarian, D., Linker, D. T., Kenyon, K. W., Cleland, J. G.F., Komajda, M., Remme, W. J., Torp-Pedersen, C., Metra, M., Poole-Wilson, P. A., on behalf of the COMET Investigators,
(2009). Years-needed-to-treat to add 1 year of life: a new metric to estimate treatment effects in randomized trials. Eur J Heart Fail
11: 256-263
[Abstract][Full Text]
Willenheimer, R.
(2009). The current role of beta-blockers in chronic heart failure: with special emphasis on the CIBIS III trial. Eur Heart J Suppl
11: A15-A20
[Abstract][Full Text]
Anand, I. S., Carson, P., Galle, E., Song, R., Boehmer, J., Ghali, J. K., Jaski, B., Lindenfeld, J., O'Connor, C., Steinberg, J. S., Leigh, J., Yong, P., Kosorok, M. R., Feldman, A. M., DeMets, D., Bristow, M. R.
(2009). Cardiac Resynchronization Therapy Reduces the Risk of Hospitalizations in Patients With Advanced Heart Failure: Results From the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) Trial. Circulation
119: 969-977
[Abstract][Full Text]
Tamaki, S., Yamada, T., Okuyama, Y., Morita, T., Sanada, S., Tsukamoto, Y., Masuda, M., Okuda, K., Iwasaki, Y., Yasui, T., Hori, M., Fukunami, M.
(2009). Cardiac Iodine-123 Metaiodobenzylguanidine Imaging Predicts Sudden Cardiac Death Independently of Left Ventricular Ejection Fraction in Patients With Chronic Heart Failure and Left Ventricular Systolic Dysfunction Results From a Comparative Study With Signal-Averaged Electrocardiogram, Heart Rate Variability, and QT Dispersion.. J Am Coll Cardiol
53: 426-435
[Abstract][Full Text]
Jhund, P. S., MacIntyre, K., Simpson, C. R., Lewsey, J. D., Stewart, S., Redpath, A., Chalmers, J. W.T., Capewell, S., McMurray, J. J.V.
(2009). Long-Term Trends in First Hospitalization for Heart Failure and Subsequent Survival Between 1986 and 2003: A Population Study of 5.1 Million People. Circulation
119: 515-523
[Abstract][Full Text]
van den Borne, S. W.M., Isobe, S., Zandbergen, H. R., Li, P., Petrov, A., Wong, N. D., Fujimoto, S., Fujimoto, A., Lovhaug, D., Smits, J. F.M., Daemen, M. J.A.P., Blankesteijn, W. M., Reutelingsperger, C., Zannad, F., Narula, N., Vannan, M. A., Pitt, B., Hofstra, L., Narula, J.
(2009). Molecular imaging for efficacy of pharmacologic intervention in myocardial remodeling.. J Am Coll Cardiol Img
2: 187-198
[Abstract][Full Text]
Pfisterer, M., Buser, P., Rickli, H., Gutmann, M., Erne, P., Rickenbacher, P., Vuillomenet, A., Jeker, U., Dubach, P., Beer, H., Yoon, S.-I., Suter, T., Osterhues, H. H., Schieber, M. M., Hilti, P., Schindler, R., Brunner-La Rocca, H.-P., for the TIME-CHF Investigators,
(2009). BNP-Guided vs Symptom-Guided Heart Failure Therapy: The Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) Randomized Trial. JAMA
301: 383-392
[Abstract][Full Text]
Hollenberg, S. M.
(2009). Heart Failure and Cardiac Pulmonary Edema. ACCP Crit Care Med Brd Rev
20: 117-128
[Full Text]
Rosenberg, J., Schou, M., Gustafsson, F., Badskjaer, J., Hildebrandt, P.
(2009). Prognostic threshold levels of NT-proBNP testing in primary care. Eur Heart J
30: 66-73
[Abstract][Full Text]
de Groote, P., Isnard, R., Clerson, P., Jondeau, G., Galinier, M., Assyag, P., Demil, N., Ducardonnet, A., Thebaut, J.-F., Komajda, M.
(2009). Improvement in the management of chronic heart failure since the publication of the updated guidelines of the European Society of Cardiology: The Impact-Reco Programme. Eur J Heart Fail
11: 85-91
[Abstract][Full Text]
McMurray, J., Petrie, M., Swedberg, K., Komajda, M., Anker, S., Gardner, R.
(2009). CHAPTER 23 Heart Failure. ESC Textbook of Cardiovascular Medicine
2: med-9780199566990-chapter-med-9780199566990-chapter
[Abstract][Full Text]
Go, A. S., Yang, J., Gurwitz, J. H., Hsu, J., Lane, K., Platt, R.
(2008). Comparative Effectiveness of Different {beta}-Adrenergic Antagonists on Mortality Among Adults With Heart Failure in Clinical Practice. Arch Intern Med
168: 2415-2421
[Abstract][Full Text]
Curtis, L. H., Greiner, M. A., Hammill, B. G., Kramer, J. M., Whellan, D. J., Schulman, K. A., Hernandez, A. F.
(2008). Early and Long-term Outcomes of Heart Failure in Elderly Persons, 2001-2005. Arch Intern Med
168: 2481-2488
[Abstract][Full Text]
Massie, B. M., Carson, P. E., McMurray, J. J., Komajda, M., McKelvie, R., Zile, M. R., Anderson, S., Donovan, M., Iverson, E., Staiger, C., Ptaszynska, A., the I-PRESERVE Investigators,
(2008). Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction. NEJM
359: 2456-2467
[Abstract][Full Text]
Henz, S., Maeder, M. T., Huber, S., Schmid, M., Loher, M., Fehr, T.
(2008). Influence of drugs and comorbidity on serum potassium in 15 000 consecutive hospital admissions. Nephrol Dial Transplant
23: 3939-3945
[Abstract][Full Text]
Holubarsch, C. J.F., Colucci, W. S., Meinertz, T., Gaus, W., Tendera, M., Survival and Prognosis: Investigation of Crataegus,
(2008). The efficacy and safety of Crataegus extract WS(R) 1442 in patients with heart failure: The SPICE trial. Eur J Heart Fail
10: 1255-1263
[Abstract][Full Text]
Iles, L., Pfluger, H., Phrommintikul, A., Cherayath, J., Aksit, P., Gupta, S. N., Kaye, D. M., Taylor, A. J.
(2008). Evaluation of Diffuse Myocardial Fibrosis in Heart Failure With Cardiac Magnetic Resonance Contrast-Enhanced T1 Mapping. J Am Coll Cardiol
52: 1574-1580
[Abstract][Full Text]
Mehta, P. A., Dubrey, S. W., McIntyre, H. F., Walker, D. M., Hardman, S. M.C., Sutton, G. C., McDonagh, T. A., Cowie, M. R.
(2008). Mode of death in patients with newly diagnosed heart failure in the general population. Eur J Heart Fail
10: 1108-1116
[Abstract][Full Text]
de Resende, M. M., Amaral, S. L., Moreno, C., Greene, A. S.
(2008). Congenic strains reveal the effect of the renin gene on skeletal muscle angiogenesis induced by electrical stimulation. Physiol. Genomics
33: 33-40
[Abstract][Full Text]
Authors/Task Force Members, , Dickstein, K., Cohen-Solal, A., Filippatos, G., McMurray, J. J.V., Ponikowski, P., Poole-Wilson, P. A., Stromberg, A., van Veldhuisen, D. J., Atar, D., Hoes, A. W., Keren, A., Mebazaa, A., Nieminen, M., Priori, S. G., Swedberg, K., ESC Committee for Practice Guidelines (CPG), , Vahanian, A., Camm, J., De Caterina, R., Dean, V., Dickstein, K., Filippatos, G., Funck-Brentano, C., Hellemans, I., Kristensen, S. D., McGregor, K., Sechtem, U., Silber, S., Tendera, M., Widimsky, P., Zamorano, J. L., Document Reviewers, , Tendera, M., Auricchio, A., Bax, J., Bohm, M., Corra, U., della Bella, P., Elliott, P. M., Follath, F., Gheorghiade, M., Hasin, Y., Hernborg, A., Jaarsma, T., Komajda, M., Kornowski, R., Piepoli, M., Prendergast, B., Tavazzi, L., Vachiery, J.-L., Verheugt, F. W. A., Zamorano, J. L., Zannad, F.
(2008). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J
29: 2388-2442
[Full Text]
Dickstein, K., Cohen-Solal, A., Filippatos, G., McMurray, J. J.V., Ponikowski, P., Poole-Wilson, P. A., Stromberg, A., van Veldhuisen, D. J., Atar, D., Hoes, A. W., Keren, A., Mebazaa, A., Nieminen, M., Priori, S. G., Swedberg, K.
(2008). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail
10: 933-989
[Full Text]
McAlister, F. A. MD MSc
(2008). The "number needed to treat" turns 20 -- and continues to be used and misused. CMAJ
179: 549-553
[Full Text]
Crespo, M. J., Cruz, N., Altieri, P. I., Escobales, N.
(2008). Enalapril and Losartan Are More Effective Than Carvedilol in Preventing Dilated Cardiomyopathy in the Syrian Cardiomyopathic Hamster. J CARDIOVASC PHARMACOL THER
13: 199-206
[Abstract]
Hauptman, P. J.
(2008). All clinical trials are not created equal: The dilemma of HEAAL. Eur J Heart Fail
10: 817-818
[Full Text]
Greenberg, B.
(2008). An ACE in the Hole: Alternative Pathways of the Renin Angiotensin System and Their Potential Role in Cardiac Remodeling. J Am Coll Cardiol
52: 755-757
[Full Text]
Schindler, C.
(2008). ACE-inhibitor, AT1-receptor-antagonist, or both? A clinical pharmacologist`s perspective after publication of the results of ONTARGET. Ther Adv Cardiovasc Dis
2: 233-248
[Abstract]
Armenian, S. H., Bhatia, S.
(2008). Cardiovascular disease after hematopoietic cell transplantation - lessons learned. haematol
93: 1132-1136
[Full Text]
Sood, M. M., Pauly, R. P., Rigatto, C., Komenda, P.
(2008). Left ventricular dysfunction in the haemodialysis population. NDT Plus
1: 199-205
[Abstract][Full Text]
Mullens, W., Abrahams, Z., Francis, G. S., Skouri, H. N., Starling, R. C., Young, J. B., Taylor, D. O., Tang, W.H. W.
(2008). Sodium nitroprusside for advanced low-output heart failure.. J Am Coll Cardiol
52: 200-207
[Abstract][Full Text]
Ootaki, C., Yamashita, M., Ootaki, Y., Kamohara, K., Weber, S., Klatte, R. S., Smith, W. A., Massiello, A. L., Emancipator, S. N., Golding, L. A.R., Fukamachi, K.
(2008). Reduced Pulsatility Induces Periarteritis in Kidney: Role of the Local Renin-Angiotensin System. J. Thorac. Cardiovasc. Surg.
136: 150-158
[Abstract][Full Text]
Fonarow, G. C., Yancy, C. W., Albert, N. M., Curtis, A. B., Stough, W. G., Gheorghiade, M., Heywood, J. T., McBride, M. L., Mehra, M. R., O'Connor, C. M., Reynolds, D., Walsh, M. N.
(2008). Heart Failure Care in the Outpatient Cardiology Practice Setting: Findings From IMPROVE HF. Circ Heart Fail
1: 98-106
[Abstract][Full Text]
Parish, R. C, Evans, J. D
(2008). Inflammation in Chronic Heart Failure. The Annals of Pharmacotherapy
42: 1002-1016
[Abstract][Full Text]
Kasama, S., Toyama, T., Sumino, H., Nakazawa, M., Matsumoto, N., Sato, Y., Kumakura, H., Takayama, Y., Ichikawa, S., Suzuki, T., Kurabayashi, M.
(2008). Prognostic Value of Serial Cardiac 123I-MIBG Imaging in Patients with Stabilized Chronic Heart Failure and Reduced Left Ventricular Ejection Fraction. JNM
49: 907-914
[Abstract][Full Text]
Femia, F. J., Maresca, K. P., Hillier, S. M., Zimmerman, C. N., Joyal, J. L., Barrett, J. A., Aras, O., Dilsizian, V., Eckelman, W. C., Babich, J. W.
(2008). Synthesis and Evaluation of a Series of 99mTc(CO)3+ Lisinopril Complexes for In Vivo Imaging of Angiotensin-Converting Enzyme Expression. JNM
49: 970-977
[Abstract][Full Text]
Becker, R. C., Meade, T. W., Berger, P. B., Ezekowitz, M., O'Connor, C. M., Vorchheimer, D. A., Guyatt, G. H., Mark, D. B., Harrington, R. A.
(2008). The Primary and Secondary Prevention of Coronary Artery Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest
133: 776S-814S
[Abstract][Full Text]
Cutler, J. A., Davis, B. R.
(2008). Thiazide-Type Diuretics and {beta}-Adrenergic Blockers as First-Line Drug Treatments for Hypertension. Circulation
117: 2691-2705
[Full Text]
Pilote, L. MD PhD, Abrahamowicz, M. PhD, Eisenberg, M. MD MPH, Humphries, K. DSc, Behlouli, H. MSc PhD, Tu, J. V. MD PhD
(2008). Effect of different angiotensin-converting-enzyme inhibitors on mortality among elderly patients with congestive heart failure. CMAJ
178: 1303-1311
[Abstract][Full Text]
Hernandez, A. F. MD MHS, Harrington, R. A. MD
(2008). Comparative effectiveness of angiotensin-converting-enzyme inhibitors: Is an ACE always an ace?. CMAJ
178: 1316-1319
[Full Text]
Schrier, R. W.
(2008). Blood Urea Nitrogen and Serum Creatinine: Not Married in Heart Failure. Circ Heart Fail
1: 2-5
[Full Text]
Anand, I. S., Rector, T. S., Kuskowski, M., Thomas, S., Holwerda, N.J., Cohn, J. N.
(2008). Effect of Baseline and Changes in Systolic Blood Pressure Over Time on the Effectiveness of Valsartan in the Valsartan Heart Failure Trial. Circ Heart Fail
1: 34-42
[Abstract][Full Text]
Verjans, J. W.H., Lovhaug, D., Narula, N., Petrov, A. D., Indrevoll, B., Bjurgert, E., Krasieva, T. B., Petersen, L. B., Kindberg, G. M., Solbakken, M., Cuthbertson, A., Vannan, M. A., Reutelingsperger, C. P.M., Tromberg, B. J., Hofstra, L., Narula, J.
(2008). Noninvasive imaging of angiotensin receptors after myocardial infarction.. J Am Coll Cardiol Img
1: 354-362
[Abstract][Full Text]
The ONTARGET Investigators,
(2008). Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events. NEJM
358: 1547-1559
[Abstract][Full Text]
Torabi, A., Cleland, J. G.F., Khan, N. K., Loh, P. H., Clark, A. L., Alamgir, F., Caplin, J. L., Rigby, A. S., Goode, K.
(2008). The timing of development and subsequent clinical course of heart failure after a myocardial infarction. Eur Heart J
29: 859-870
[Abstract][Full Text]
Sharma, V., Dhillon, P., Wambolt, R., Parsons, H., Brownsey, R., Allard, M. F., McNeill, J. H.
(2008). Metoprolol improves cardiac function and modulates cardiac metabolism in the streptozotocin-diabetic rat. Am. J. Physiol. Heart Circ. Physiol.
294: H1609-H1620
[Abstract][Full Text]
McMurray, J. J.V., Carson, P. E., Komajda, M., McKelvie, R., Zile, M. R., Ptaszynska, A., Staiger, C., Donovan, J. M., Massie, B. M.
(2008). Heart failure with preserved ejection fraction: Clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial. Eur J Heart Fail
10: 149-156
[Abstract][Full Text]
Weir, R.A.P., McMurray, J. J.V., Puu, M., Solomon, S. D., Olofsson, B., Granger, C. B., Yusuf, S., Michelson, E. L., Swedberg, K., Pfeffer, M. A., CHARM Investigators,
(2008). Efficacy and tolerability of adding an angiotensin receptor blocker in patients with heart failure already receiving an angiotensin-converting inhibitor plus aldosterone antagonist, with or without a beta blocker. Findings from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial. Eur J Heart Fail
10: 157-163
[Abstract][Full Text]
Shankar, S. M., Marina, N., Hudson, M. M., Hodgson, D. C., Adams, M. J., Landier, W., Bhatia, S., Meeske, K., Chen, M. H., Kinahan, K. E., Steinberger, J., Rosenthal, D.
(2008). Monitoring for Cardiovascular Disease in Survivors of Childhood Cancer: Report From the Cardiovascular Disease Task Force of the Children's Oncology Group. Pediatrics
121: e387-e396
[Abstract][Full Text]
Casaclang-Verzosa, G., Gersh, B. J., Tsang, T. S.M.
(2008). Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation.. J Am Coll Cardiol
51: 1-11
[Abstract][Full Text]
Perez de Isla, L., Zamorano, J., Quezada, M., Almeria, C., Rodrigo, J. L., Serra, V., Garcia Rubira, J. C., Ortiz, A. F., Macaya, C.
(2007). Functional mitral regurgitation after a first non-ST-segment elevation acute coronary syndrome: contribution to congestive heart failure. Eur Heart J
28: 2866-2872
[Abstract][Full Text]
Alsafwah, S., LaGuardia, S. P., Arroyo, M., Dockery, B. K., Bhattacharya, S. K., Ahokas, R. A., Newman, K. P.
(2007). Congestive Heart Failure is a Systemic Illness: A Role for Minerals and Micronutrients. Clin Med Res
5: 238-243
[Abstract][Full Text]
Remme, W. J.
(2007). Filling the gap between guidelines and clinical practice in heart failure treatment -- Still a far cry from reality. Eur J Heart Fail
9: 1143-1145
[Full Text]
